FDA Approves Veklury (remdesivir) for the Treatment of COVID-19 FOSTER CITY, Calif.–(BUSINESS WIRE)–Oct. 22, 2020– Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the U.S. Food and Drug Administration (FDA) has approved the antiviral drug Veklury (remdesivir) for the treatment of patients with COVID-19 requiring hospitalization. As an antiviral drug, Veklury works to stop replication… Read More »
Researchers from 68 sites across the country, led by David E. Leaf and Shruti Gupta from the Division of Renal Medicine at Harvard-affiliated Brigham and Women’s Hospital, have investigated the effects of the anti-inflammatory drug tocilizumab on critically ill patients with laboratory-confirmed COVID-19. Unlike steroids, which suppress the immune system more broadly, tocilizumab specifically inhibits the receptor for… Read More »
Sex, age, and severity of disease may be useful in identifying COVID-19 survivors who are likely to have high levels of antibodies that can protect against the disease, according to a new study co-led by researchers at Johns Hopkins Bloomberg School of Public Health. The findings suggest that older males who have recovered from COVID-19… Read More »
Trump also suggests that’s why he initially pushed so hard for the use of the malaria drug hydroxychloroquine, because the malaria drug had already been tested and approved for other uses. “Well, we’re doing great on vaccines,” Woodward quotes Trump as saying in his latest book, “Rage.” “The problem with a vaccine is a vaccine… Read More »
[unable to retrieve full-text content] CNN.com – RSS Channel – App Health Section